| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |